|
Best-Charts: stock chart, stock market analysis
Content: stock chart parameter optimization, optimal buy and sell signals, back testing, Bullish Bearish Indicator, market trend forecast, stock market analysis, stock charts.
HotCopper
Content: Discussion forum for investors. By HotCopper Australia.
FREE End of Day Stock Market Data and Historical Quotes
Content: Free end of day stock market data and historical quotes for many of the world's top exchanges including NASDAQ, NYSE, Toronto, FTSE, SGX, HKSE, Paris, Milan and Madrid.
Historical Prices
Content: Data and information is provided for informational purposes only, and is notintended for trading purposes. Neither Yahoo nor any of its data or content providers (suchas CSI) shall be liable for any errors or delays in the content, or for any actions...
Quotes Commodities futures quotes stock market historical data
Content: Investing and trading - How and where to do it online, stock picks, stock quotes, trading methods and techniques.
Yahoo! Finance
Content: Kentucky farmer Paul Hornback strips tobacco leaves from their stocks, forming bales bound for America's cigarette factories. It is timeless autumn toil in a land where the golden dried leaves were once a currency of their own
Dow Theory Forecasts Stock Market Investment Services - Historical Market Stock
Content: Dow Theory Forecasts offers a wealth of valuable moneymaking investment tools, services, reports, advice. Information includes market research and trend analysis. - historical market stock trends
Dial & Chart provide end-of-day stock market data, historical data and charting
Content: Dial & Chart provide end-of-day stock market data for Australian and overseas markets for the purpose of charting.
The University at Albany website is temporarily unavailable
Content: The University at Albany website is temporarily unavailable due to scheduled infrastructure upgrades
BigCharts - Charting a World of Investment Information
Content: NEW YORK (CBS.MW) -- Pfizer said Sunday said it has reached an agreement to buy Michigan-based drug developer Esperion Therapeutics for about $1.3 billion cash to gain access to its promising cholesterol treatment
|